Q & A

Friday, April 28, 2023

2:58 PM – 3:04 PM CST

Location: N427A

Moderator(s)

JR

Jennifer Rider, PhD,MPH (she/her/hers)

Executive Director, RWE Solutions, GU Cancers

Speaker(s)

JB

Jesse Berlin, ScD
Neil B. Desai, MD,MHS

University of Texas Southwestern
Daniel Spratt, MD

Chair and Professor
UH Seidman Cancer Center/Case Western Reserve University
Andrew Vickers, PhD

Memorial Sloan Kettering Cancer Center

Clinical Trials provide the evidence for determining and improving on the standards of care across urologic oncology. There are many requirements necessary to effectively generate, organize and execute a clinical trial. From producing a clinical question in the form of a hypothesis, to engendering support and funding, navigating the barriers, enhancing the efforts with correlative science and of course successful execution of the protocol itself. In this symposium we explore what makes for a successful clinical trial from the basics of obtaining necessary resources to the challenges an investigator faces when attempting to address an unmet need in the care of urologic oncology patients.

Learning Objectives:

Understand how to identify a testable hypothesis for clinical trial design.
Determine the best mechanism by which their trial can be achieved.
Identify and engage the multiple stakeholders necessary to execute a clinical trial successfully.